-
-
-
-
-
-
-
PharmaDrug Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus
-
-
-
-
-
-
-
PharmaTher Launches Strategic Initiative to Pursue Health Canada Approval for Generic Semaglutide in Canada, Building on FDA-Approved Ketamine Success
-
-
-
-
-
-
-
PharmaTher Advances Phase 3 FDA Package for Ketamine in LID-Parkinson's Disease
-
-
-
-
-
-
-
PharmaTher Announces FDA Approval of Ketamine (KETARx(TM))
-
-
-
-
-
-
435,717 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

